Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
نویسندگان
چکیده
منابع مشابه
[Research ethics and conflicts of interest].
Translating research results to clinical settings requires that both researchers and clinicians work together with pharmaceutical companies. At the same time, however, it must be recognized that pharmaceutical companies are basically profit-motivated organizations. When pharmaceutical companies develop deeper doctor-patient relationships, the benefits of individual doctors and organizations ine...
متن کاملEvidence-based decision-making within Australia's pharmaceutical benefits scheme.
In Australia, most prescription drugs are subsidized through the Pharmaceutical Benefits Scheme (PBS), one of several government programs in which evidence-based decision making is applied to the funding of health technologies. PBS processes are intended to ensure "value for money" for the Australian taxpayer and to support affordable, equitable access to prescription medicines; they are not in...
متن کاملDrug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
Australia has had a government subsidized universal system of pharmaceutical provision for 50 years. The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. It incorporates patient copayments (with differentials for the gener...
متن کاملFinding Default Barrier and Optimal Cutoff Rate in KMV Structural Model based on the best Ranking of Companies
According to the adverse consequences that are brought by financial distress for companies, economy and financial –monetary institutions, the use of methods that can predict the occurrence of financial failure and prevent the loss of wealth is of great importance. The major models of credit risk assessment are based on retrospective information and using the methods which use the updated market...
متن کاملFaces of Pricing and profit planning at the doorstep of the EU: Government pricing policy in the innovative pharmaceutical sector in Turkey
The majority of research on the pharmaceutical sector has focused on an overall micro economic, medical oriented welfare issues, whereas the marketing management role of the innovative drug manufacturer has to a large extent been disregarded. Using the case of Turkey, through a series of in-depth interviews with highly innovative companies, other marketing management possibilities to develop pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Yale journal of health policy, law, and ethics
دوره 4 2 شماره
صفحات -
تاریخ انتشار 2004